Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 146,320 shares at $1.96 ($285K) on 2024-05-03, disclosed to the SEC on 2024-05-03.
Scheduled sale ($285k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.93 | 73,824 | $142K | 50.1% |
| 2 | $1.96 | 36,248 | $71K | 25.0% |
| 3 | $1.96 | 36,248 | $71K | 25.0% |
| Total | $1.94 avg | 146,320 | $285K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |